AllSquare Wealth Management’s Moderna MRNA Stock Holding History

AllSquare Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.58K	Hold	100	–	–	﹤0.01%	458
2025 Q2	$2.76K	Sell	100 -100	-50%	-$2.63K	﹤0.01%	458
2025 Q1	$5.67K	Hold	200	–	–	﹤0.01%	423
2024 Q4	$8.32K	Hold	200	–	–	﹤0.01%	396
2024 Q3	$13.4K	Hold	200	–	–	0.01%	354
2024 Q2	$23.8K	Hold	200	–	–	0.01%	280
2024 Q1	$21.3K	Hold	200	–	–	0.01%	290
2023 Q4	$19.9K	Hold	200	–	–	0.01%	297
2023 Q3	$20.7K	Hold	200	–	–	0.01%	287
2023 Q2	$25.8K	Hold	200	–	–	0.02%	276
2023 Q1	$30.7K	Hold	200	–	–	0.02%	265
2022 Q4	$35.9K	Hold	200	–	–	0.02%	232
2022 Q3	$24K	Hold	200	–	–	0.02%	264
2022 Q2	$29K	Buy	200 +50	+33%	+$7.15K	0.02%	257
2022 Q1	$26K	Buy	+150	New	+$25.3K	0.02%	292

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AllSquare Wealth Management's MRNA Position: Q3 2025 in Review

AllSquare Wealth Management held its Moderna (MRNA) position steady in Q3 2025 at 100 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

AllSquare Wealth Management first reported a position in MRNA in Q1 2022 and has held it in 15 quarters since. The position peaked at $35.9K in Q4 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

AllSquare Wealth Management held 100 shares of Moderna worth $2.58K as of Q3 2025.
AllSquare Wealth Management left its Moderna share count unchanged in Q3 2025.
Moderna made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #458 holding.
AllSquare Wealth Management first reported a position in Moderna in Q1 2022 and has held it in 15 quarters since.
AllSquare Wealth Management's Moderna position peaked at $35.9K in Q4 2022.
643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.